Drake R E, Mueser K T, Torrey W C, Miller A L, Lehman A F, Bond G R, Goldman H H, Leff H S
Psychiatric Research Center, Dartmouth Medical School, 2 Whipple Place, Suite 202, Lebanon, NH 03766, USA.
Curr Psychiatry Rep. 2000 Oct;2(5):393-7. doi: 10.1007/s11920-000-0021-7.
People with schizophrenia can be helped greatly with pharmacologic and psychosocial interventions that are known to be effective. Several interventions are now supported by research: use of medications following specific guidelines, training in illness self-management, case management based on principles of assertive community treatment, family psychoeducation, supported employment, and integrated substance abuse treatment. However, few patients actually receive these evidence-based interventions because they are not provided in routine mental health settings. Therefore, implementing effective treatments in mental health treatment programs is a critical challenge for the field. We review the six areas of evidence-based treatment of schizophrenia, as well as knowledge regarding implementation of mental health programs in routine practice settings.
精神分裂症患者可通过已知有效的药物和心理社会干预措施得到极大帮助。目前有多项干预措施得到了研究支持：遵循特定指南使用药物、疾病自我管理培训、基于积极社区治疗原则的个案管理、家庭心理教育、支持性就业以及综合药物滥用治疗。然而，很少有患者实际接受这些循证干预措施，因为它们在常规心理健康环境中并未提供。因此，在心理健康治疗项目中实施有效治疗是该领域面临的一项关键挑战。我们回顾了精神分裂症循证治疗的六个领域，以及在常规实践环境中实施心理健康项目的相关知识。
